Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
2,07 USD | -5,91% |
|
-15,25% | -50,71% |
Métier
Nombre d'employés: 9
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
James Sapirstein
CEO | Chief Executive Officer | 63 | 08/10/19 |
Sarah Romano
DFI | Director of Finance/CFO | 44 | 01/03/22 |
Amy Chandler
CMP | Compliance Officer | 56 | - |
Martin Krusin
PRN | Corporate Officer/Principal | - | 01/01/14 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Director/Board Member | 78 | 03/03/17 | |
Ed Borkowski
BRD | Director/Board Member | 64 | 01/05/15 |
Alastair Riddell
BRD | Director/Board Member | 74 | 01/09/15 |
James Sapirstein
CEO | Chief Executive Officer | 63 | 08/10/19 |
Mary Coelho
BRD | Director/Board Member | 62 | 11/08/21 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 2 750 090 | 2 594 361 ( 94,34 %) | 0 | 94,34 % |
Coordonnées société
First Wave Biopharma, Inc.
777 Yamato Road Suite 502
33431, Boca Raton
+561 589 7020
http://www.firstwavebio.com![Adresse Entero Therapeutics, Inc.(ENTO)](https://cdn.zonebourse.com/static/address/30506551.png)
Secteur
![Consensus](/images/consensus_flch.gif)
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
-50,71% | 5,12 M | |
+40,80% | 53,67 Md | |
+35,79% | 38,86 Md | |
-8,05% | 38,76 Md | |
-8,98% | 27,27 Md | |
+10,69% | 25,91 Md | |
-16,21% | 20,29 Md | |
+31,00% | 12,78 Md | |
+28,51% | 12,18 Md | |
-1,67% | 11,96 Md |
- Bourse
- Actions
- Action ENTO
- Société Entero Therapeutics, Inc.